|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Tracon Pharmaceuticals, Inc. (TCON) |
|
|
$0.26 0.00 (0.00%) as of 4:30 Fri 4/5
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,680,000 |
Market
Cap: |
3.49(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.1322 - $0.67 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma in North America. Other clinical stage oncology product candidates include: YH001, which is a monospecific investigational CTLA-4 antibody, that Co. licensed from Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., TRC102, which is a small molecule for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody for the treatment of solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,418,993 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,892,637 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
30 |
Total Shares Sold |
0 |
0 |
4,764,008 |
4,765,667 |
Total Sell Value |
$0 |
$0 |
$1,401,571 |
$1,403,938 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
1 |
3 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Opaleye Management Inc. |
10% Owner |
|
2020-09-01 |
4 |
B |
$2.04 |
$81,768 |
I/I |
40,000 |
1,540,946 |
1.5 |
332% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-08-31 |
4 |
B |
$1.67 |
$530,455 |
I/I |
302,150 |
1,502,346 |
1.5 |
433% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-08-28 |
4 |
B |
$1.78 |
$106,974 |
I/I |
60,000 |
210,000 |
1.5 |
502% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-08-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,172,842 |
|
501% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-08-27 |
4 |
B |
$1.71 |
$312,949 |
I/I |
183,354 |
1,206,196 |
1.5 |
501% |
|
Theuer Charles |
President and CEO |
|
2020-08-21 |
4 |
B |
$1.56 |
$8,307 |
D/D |
5,325 |
171,882 |
2.81 |
519% |
|
Theuer Charles |
President and CEO |
|
2020-08-20 |
4 |
B |
$1.58 |
$47,400 |
D/D |
30,000 |
166,557 |
2.81 |
552% |
|
Theuer Charles |
President and CEO |
|
2020-08-18 |
4 |
B |
$1.63 |
$72,851 |
D/D |
44,743 |
136,557 |
2.81 |
561% |
|
Theuer Charles |
President and CEO |
|
2020-08-14 |
4 |
B |
$1.70 |
$170 |
D/D |
100 |
91,814 |
2.73 |
462% |
|
Theuer Charles |
President and CEO |
|
2020-08-13 |
4 |
B |
$1.65 |
$8,250 |
D/D |
5,000 |
91,714 |
2.81 |
402% |
|
Theuer Charles |
President and CEO |
|
2020-08-12 |
4 |
B |
$1.67 |
$26,250 |
D/D |
15,000 |
86,714 |
2.81 |
414% |
|
Theuer Charles |
President and CEO |
|
2020-06-24 |
4 |
B |
$1.90 |
$18,801 |
D/D |
9,895 |
71,714 |
2.81 |
164% |
|
Pelletier Saundra L |
Director |
|
2020-06-15 |
4 |
B |
$2.07 |
$6,209 |
D/D |
3,000 |
5,500 |
2.39 |
134% |
|
Pelletier Saundra L |
Director |
|
2020-06-11 |
4 |
B |
$2.00 |
$5,000 |
D/D |
2,500 |
2,500 |
2.39 |
128% |
|
Theuer Charles |
President and CEO |
|
2020-05-22 |
4 |
B |
$1.89 |
$20,119 |
D/D |
10,592 |
61,819 |
2.81 |
168% |
|
Theuer Charles |
President and CEO |
|
2020-03-13 |
4 |
B |
$1.13 |
$4,624 |
D/D |
4,100 |
50,877 |
2.73 |
66% |
|
Theuer Charles |
President and CEO |
|
2020-03-12 |
4 |
B |
$1.17 |
$11,803 |
D/D |
10,000 |
46,777 |
2.81 |
62% |
|
Theuer Charles |
President and CEO |
|
2020-03-11 |
4 |
B |
$1.66 |
$16,837 |
D/D |
10,000 |
36,777 |
2.81 |
33% |
|
Theuer Charles |
President and CEO |
|
2020-03-10 |
4 |
B |
$1.87 |
$18,691 |
D/D |
10,000 |
26,777 |
2.81 |
4% |
|
Wiggins Mark C |
Chief Business Officer |
|
2020-01-23 |
4 |
B |
$4.02 |
$20,103 |
D/D |
5,000 |
5,000 |
2.74 |
-47% |
|
Theuer Charles |
President and CEO |
|
2020-01-22 |
4 |
D |
$3.76 |
$3,493 |
D/D |
(929) |
16,777 |
|
- |
|
Brown Scott B. |
Chief Accounting Officer (PAO) |
|
2020-01-22 |
4 |
D |
$3.76 |
$68 |
D/D |
(18) |
1,428 |
|
- |
|
Wang Theodore T |
10% Owner |
|
2019-12-09 |
4 |
S |
$2.92 |
$993,191 |
I/I |
(340,134) |
76,048 |
|
- |
|
Wang Theodore T |
10% Owner |
|
2019-12-05 |
4 |
S |
$3.05 |
$134,188 |
I/I |
(43,996) |
416,182 |
|
- |
|
Brown Scott B. |
Chief Accounting Officer (PAO) |
|
2019-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,962 |
|
- |
|
241 Records found
|
|
Page 5 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|